281 related articles for article (PubMed ID: 36923655)
1. Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder.
Khoja S; Haile MT; Chen LY
Front Mol Neurosci; 2023; 16():1125087. PubMed ID: 36923655
[TBL] [Abstract][Full Text] [Related]
2. Neurexin gene family variants as risk factors for autism spectrum disorder.
Wang J; Gong J; Li L; Chen Y; Liu L; Gu H; Luo X; Hou F; Zhang J; Song R
Autism Res; 2018 Jan; 11(1):37-43. PubMed ID: 29045040
[TBL] [Abstract][Full Text] [Related]
3. Modeling a Neurexin-3α Human Mutation in Mouse Neurons Identifies a Novel Role in the Regulation of Transsynaptic Signaling and Neurotransmitter Release at Excitatory Synapses.
Restrepo S; Langer NJ; Nelson KA; Aoto J
J Neurosci; 2019 Nov; 39(46):9065-9082. PubMed ID: 31578233
[TBL] [Abstract][Full Text] [Related]
4. SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.
Gan KJ; Südhof TC
J Neurosci; 2020 Oct; 40(42):8088-8102. PubMed ID: 32973045
[TBL] [Abstract][Full Text] [Related]
5. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.
Arons MH; Thynne CJ; Grabrucker AM; Li D; Schoen M; Cheyne JE; Boeckers TM; Montgomery JM; Garner CC
J Neurosci; 2012 Oct; 32(43):14966-78. PubMed ID: 23100419
[TBL] [Abstract][Full Text] [Related]
6. Presenilin/γ-secretase regulates neurexin processing at synapses.
Saura CA; Servián-Morilla E; Scholl FG
PLoS One; 2011 Apr; 6(4):e19430. PubMed ID: 21559374
[TBL] [Abstract][Full Text] [Related]
7. Extracellular domains of alpha-neurexins participate in regulating synaptic transmission by selectively affecting N- and P/Q-type Ca2+ channels.
Zhang W; Rohlmann A; Sargsyan V; Aramuni G; Hammer RE; Südhof TC; Missler M
J Neurosci; 2005 Apr; 25(17):4330-42. PubMed ID: 15858059
[TBL] [Abstract][Full Text] [Related]
8. Neuroligin-3: A Circuit-Specific Synapse Organizer That Shapes Normal Function and Autism Spectrum Disorder-Associated Dysfunction.
Uchigashima M; Cheung A; Futai K
Front Mol Neurosci; 2021; 14():749164. PubMed ID: 34690695
[TBL] [Abstract][Full Text] [Related]
9. Implications of Cell Adhesion Molecules in Autism Spectrum Disorder Pathogenesis.
Sindi IA
J Microsc Ultrastruct; 2023; 11(4):199-205. PubMed ID: 38213654
[TBL] [Abstract][Full Text] [Related]
10. Balance within the Neurexin Trans-Synaptic Connexus Stabilizes Behavioral Control.
Clarke RA; Eapen V
Front Hum Neurosci; 2014; 8():52. PubMed ID: 24578685
[TBL] [Abstract][Full Text] [Related]
11. The neuroligins and the synaptic pathway in Autism Spectrum Disorder.
Trobiani L; Meringolo M; Diamanti T; Bourne Y; Marchot P; Martella G; Dini L; Pisani A; De Jaco A; Bonsi P
Neurosci Biobehav Rev; 2020 Dec; 119():37-51. PubMed ID: 32991906
[TBL] [Abstract][Full Text] [Related]
12. Neurexin dysfunction in neurodevelopmental and neuropsychiatric disorders: a PRIMSA-based systematic review through iPSC and animal models.
Shan D; Song Y; Zhang Y; Ho CW; Xia W; Li Z; Ge F; Ou Q; Dai Z; Dai Z
Front Behav Neurosci; 2024; 18():1297374. PubMed ID: 38380150
[TBL] [Abstract][Full Text] [Related]
13. Pan-neurexin perturbation results in compromised synapse stability and a reduction in readily releasable synaptic vesicle pool size.
Quinn DP; Kolar A; Wigerius M; Gomm-Kolisko RN; Atwi H; Fawcett JP; Krueger SR
Sci Rep; 2017 Feb; 7():42920. PubMed ID: 28220838
[TBL] [Abstract][Full Text] [Related]
14. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.
Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY
J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787
[TBL] [Abstract][Full Text] [Related]
15. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
[TBL] [Abstract][Full Text] [Related]
16. Rare deletions at the neurexin 3 locus in autism spectrum disorder.
Vaags AK; Lionel AC; Sato D; Goodenberger M; Stein QP; Curran S; Ogilvie C; Ahn JW; Drmic I; Senman L; Chrysler C; Thompson A; Russell C; Prasad A; Walker S; Pinto D; Marshall CR; Stavropoulos DJ; Zwaigenbaum L; Fernandez BA; Fombonne E; Bolton PF; Collier DA; Hodge JC; Roberts W; Szatmari P; Scherer SW
Am J Hum Genet; 2012 Jan; 90(1):133-41. PubMed ID: 22209245
[TBL] [Abstract][Full Text] [Related]
17. Neurexin-2 restricts synapse numbers and restrains the presynaptic release probability by an alternative splicing-dependent mechanism.
Lin PY; Chen LY; Zhou P; Lee SJ; Trotter JH; Südhof TC
Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2300363120. PubMed ID: 36961922
[TBL] [Abstract][Full Text] [Related]
18. Conditional deletion of Neurexin-2 alters neuronal network activity in hippocampal circuitries and leads to spontaneous seizures.
Haile MT; Khoja S; de Carvalho G; Hunt RF; Chen LY
Transl Psychiatry; 2023 Mar; 13(1):97. PubMed ID: 36941261
[TBL] [Abstract][Full Text] [Related]
19. Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders.
Cao X; Tabuchi K
Neurosci Res; 2017 Mar; 116():3-9. PubMed ID: 27664583
[TBL] [Abstract][Full Text] [Related]
20. Neurexin-2: An inhibitory neurexin that restricts excitatory synapse formation in the hippocampus.
Lin PY; Chen LY; Jiang M; Trotter JH; Seigneur E; Südhof TC
Sci Adv; 2023 Jan; 9(1):eadd8856. PubMed ID: 36608123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
